Blacksmith Medicines Revenue and Competitors
Estimated Revenue & Valuation
- Blacksmith Medicines's estimated annual revenue is currently $930k per year.
- Blacksmith Medicines's estimated revenue per employee is $93,000
Employee Data
- Blacksmith Medicines has 10 Employees.
- Blacksmith Medicines grew their employee count by 0% last year.
Blacksmith Medicines's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, COO & VP Discovery | Reveal Email/Phone |
2 | VP, Translational Sciences, Blacksmith Medicines | Reveal Email/Phone |
3 | Associate Director Platform Sciences | Reveal Email/Phone |
4 | Director, Biochemistry | Reveal Email/Phone |
5 | Discovery Biology | Reveal Email/Phone |
6 | Sr. Scientist | Reveal Email/Phone |
7 | Office Lead | Reveal Email/Phone |
Blacksmith Medicines Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 15 | -32% | N/A | N/A |
#10 | $10.1M | 48 | -9% | N/A | N/A |
What Is Blacksmith Medicines?
Purpose-Built Platform for Human Metalloenzyme-Targeted Medicines
keywords:N/A
N/A
Total Funding
10
Number of Employees
$930k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Blacksmith Medicines News
Blacksmith Medicines, a San Diego, CA-based biotechnology company focused on creating novel medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, raised a seed funding of undisclosed amount. The company has also entered into a research collaboration with Eli ...
These are a few US-based startups that raised funding today: 1. Blacksmith Medicines Raises Seed Funding. Blacksmith Medicines is a biotechnology company that creates novel medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes. Its metalloenzyme platform is ...
SAN DIEGO, Jan. 8, 2021 /PRNewswire/ -- Blacksmith Medicines, Inc. (Blacksmith), a biotechnology company focused on creating novel medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, announced today that it has secured seed funding and has entered into a ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2M | 10 | -37% | N/A |
#2 | $2.1M | 10 | -41% | N/A |
#3 | $2.9M | 10 | -41% | N/A |
#4 | $0.4M | 10 | 0% | $21.5M |
#5 | $0.9M | 10 | N/A | N/A |